India · Delayed Price · Currency is INR Verve Therapeutics Statistics
Total Valuation
BOM:509930 has a market cap or net worth of INR 527.23 billion. The enterprise value is 518.54 billion.
| Market Cap | 527.23B |
| Enterprise Value | 518.54B |
Important Dates
The last earnings date was Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | Jun 20, 2025 |
Share Statistics
| Current Share Class | 127.03M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 64.25M |
Valuation Ratios
The trailing PE ratio is 59.25 and the forward PE ratio is 49.94.
| PE Ratio | 59.25 |
| Forward PE | 49.94 |
| PS Ratio | 5.06 |
| PB Ratio | 9.31 |
| P/TBV Ratio | 9.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 58.28 |
| EV / Sales | 4.98 |
| EV / EBITDA | 34.63 |
| EV / EBIT | 46.10 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | n/a |
| Interest Coverage | 179.71 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.66% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 19.39M |
| Profits Per Employee | 1.66M |
| Employee Count | 5,374 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:509930 has paid 2.57 billion in taxes.
| Income Tax | 2.57B |
| Effective Tax Rate | 22.44% |
Stock Price Statistics
The stock price has decreased by -17.48% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -17.48% |
| 50-Day Moving Average | 4,301.00 |
| 200-Day Moving Average | 4,093.29 |
| Relative Strength Index (RSI) | 43.30 |
| Average Volume (20 Days) | 6,292 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:509930 had revenue of INR 104.19 billion and earned 8.90 billion in profits. Earnings per share was 70.05.
| Revenue | 104.19B |
| Gross Profit | 32.23B |
| Operating Income | 10.17B |
| Pretax Income | 11.47B |
| Net Income | 8.90B |
| EBITDA | 13.71B |
| EBIT | 10.17B |
| Earnings Per Share (EPS) | 70.05 |
Balance Sheet
The company has 9.44 billion in cash and 758.00 million in debt, giving a net cash position of 8.68 billion.
| Cash & Cash Equivalents | 9.44B |
| Total Debt | 758.00M |
| Net Cash | 8.68B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 56.60B |
| Book Value Per Share | 445.61 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 30.94%, with operating and profit margins of 9.76% and 8.54%.
| Gross Margin | 30.94% |
| Operating Margin | 9.76% |
| Pretax Margin | 11.01% |
| Profit Margin | 8.54% |
| EBITDA Margin | 13.16% |
| EBIT Margin | 9.76% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 34.00, which amounts to a dividend yield of 0.79%.
| Dividend Per Share | 34.00 |
| Dividend Yield | 0.79% |
| Dividend Growth (YoY) | 13.33% |
| Years of Dividend Growth | 5 |
| Payout Ratio | n/a |
| Buyback Yield | 0.01% |
| Shareholder Yield | 0.80% |
| Earnings Yield | 1.69% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 18, 2010. It was a forward split with a ratio of 5.
| Last Split Date | Oct 18, 2010 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |